Loading...
XNAS
VMD
Market cap264mUSD
Dec 05, Last price  
6.77USD
1D
0.00%
1Q
-1.60%
IPO
277.45%
Name

Viemed Healthcare Inc

Chart & Performance

D1W1MN
XNAS:VMD chart
P/E
23.46
P/S
1.18
EPS
0.29
Div Yield, %
Shrs. gr., 5y
0.53%
Rev. gr., 5y
22.82%
Revenues
224m
+22.54%
23,289,00034,601,44831,356,00046,928,00065,271,00080,256,000131,309,000117,062,000138,832,000183,008,000224,257,000
Net income
11m
+9.98%
9,453,0008,927,3561,228,0008,176,00010,177,0008,525,00031,530,0009,126,0006,222,00010,243,00011,265,000
CFO
39m
-13.54%
7,591,0009,381,4146,414,00012,024,00022,368,00019,087,00035,110,00022,494,00027,748,00045,212,00039,089,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME and patient medical services. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
IPO date
Dec 22, 2017
Employees
974
Domiciled in
US
Incorporated in
CA

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT